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Porphyria in Africa
BY
A. G. SHAPER, m .b ., m .r .c .p ., d.t .m . & h .
Makerere College Medical School, Kampala, Uganda.
Until recently, porphyria has been regarded as 
a rare condition in most countries and has 
merited but passing comment in standard text­
books of medicine. As this is a condition 
requiring a high index of diagnostic suspicion, 
it seems a useful task to present the common 
features of the disorder as seen in Europeans 
and Africans, to comment on the procedures 
necessary for diagnosis and to speculate on the 
factors precipitating its onset. It is becoming 
increasingly apparent that porphyria occurs 
frequently in South and Central Africa, both 
amongst those of European and African stock. 
As in other countries, the increase in diagnosis 
is due to the wider knowledge of its clinical 
manifestations and to the combined interest of 
both clinicians and biochemists. Since Barnes 
(1945) first described a series of South African 
cases, several of whom were African, the number 
reported has multiplied rapidly’. Porphyria has 
now been found in all parts of South Africa 
and more recently in Central Africa, where 
Gelfand (1955 and 1956) has described cases 
seen in Southern Rhodesia. A case of acute 
porphyria has been described in a West African 
in England; in the Sudan, congenital porphyria 
has been reported in siblings and from Dakar 
a child of ten with hepatic porphyria has re­
cently been reported. No cases have as yet been 
reported from any of the East African territories.
S tructure, B io sy n th esis and E xcretion
Precise classification, rational investigation 
and treatment of this disorder can only be 
achieved by some understanding of the biosyn­
thesis and excretion of the porphyrins and their 
abnormalities in disease. The porphyrins occur 
in both the plant and animal world and in 
both, porphyrin complexes mediate vital cellular 
processes. They are pigments composed of four
pyrrole rings connected by four methane bridges 
to form a large ring structure, and they differ 
from one another in structure and properties, 
depending on the character of the substituent 
groups on the eight free corners of the four 
pyrrole nuclei (Fig. 1),. Chlorophyll, essential 
for photosynthesis, is a magnesium-porphyrin 
compound and the structural relationship be­
tween chlorophyll and haem, an iron-porphyrin 
compound, is obvious. In the human body the 
release of energy from the products of photo­
synthesis depends on those porphyrin complexes 
which incorporate haem in their structure. 
These porphyrin complexes are known as re­
spiratory enzymes and are responsible for the 
transport, storage and exchange of oxygen and 
are concerned with the oxidation of cellular con­
stituents. It can be .seen that from the initial 
fixation of solar energy in green plants to its 
eventual utilisation in man, porphyrins play a 
vital role.
Although many types of porphyrins have been 
synthesised and both uroporphyrin and copro­
porphyrin can theoretically exist in isomeric 
types I-IV, only two main isomers have so far 
been isolated in nature, Type I and Type III. 
Uroporphyrin and coproporphyrin are so de­
signated because they were originally isolated 
from the urine and stools respectively; it has 
now been established that either or both may 
appear in the urine or faeces (Fig. 2 ).
In health, large amounts of Type III por­
phyrins are synthesised in the body and utilised 
for the formation of haemoglobin and the other 
respiratory factors, while only minute amounts 
are excreted. Very small quantities of Type I 
are also produced, apparently as a by-product 
of normal haematopoiesis; these serve no useful 
purpose and are excreted largely by the liver 
in the bile and eventually in the faeces and 
urine. In man, the combination of ferrous iron 
with protoporphyrin Type III constitutes the 
prosthetic group for the haem compounds, i.e., 
haemoglobin, myohaemoglobin, cytochromes, 
catalases, peroxidases and other respiratory 
enzymes. Primitive red cells contain porphyrins
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rather than haemoglobin, the amount of por­
phyrin decreasing and haemoglobin increasing 
as the cell matures. Normal red blood cells still 
contain small amounts of protoporphyrin and 
traces of Type III coproporphyrin. The im­
portance of the role played in metabolic pro­
cesses by the respiratory enzymes is self-evident 
and makes it a shade easier to understand the 
widespread tissue damage which can take place 
in porphyria when the biosynthesis of these 
porphyrin substances is disturbed.
N ormal P atterns of E xcretion
Coproporphyria /, representing the minor 
metabolic pathway is not used in the organism, 
and all that is formed is excreted in the urine, 
and via the bile, in the faeces, . The major 
metabolic product, coproporphyria III, is largely 
converted to protoporphyrin III. The minute 
amount (.05 per cent.) not converted is ex­
creted in the urine, and via the bile, in the 
faeces. There appears to be a significant indi­
vidual and geographical variation in the ratio 
of the urinary coproporphyrin isomers excreted; 
recent studies suggest that in children and adults 
the major part of the urinary coproporphyrin 
is Type III.
Uroporphyria is excreted in the urine in 
small amounts, detectable only by very precise 
methods. However, in adults suffering from a 
wide variety of conditions mostly severe and 
potentially fatal (cirrhosis and leukaemia, bar­
biturate and alcohol addiction), uroporphyrin
HAEM
. is excreted in amounts larger than the traces 
normally found, i.e., moderate uroporphyrinuria 
under such conditions is not evidence of an 
inborn metabolic error. The metabolic error 
which exists in porphyria is a quantitative 
rather than a qualitative one, and it is excessive 
uroporphyrin excretion which is characteristic 
of porphyria.
Porphobiliaogea, a colourless non-fluorescent 
monopyrrole precursor of uroporphyrin, is noL 
normally present in the urine, but is charac­
teristically present in those cases of acute 
porphyria' with abdominal pain and/or neuro­
logical disturbances.
Thus the abnormal types of porphyrin ex­
cretion which we see in porphyria reflect de­
fective porphyrin synthesis, an imbalance in 
the chain of events depicted in Fig. 2.
Ilaematoporphyriauria.—This term is fre­
quently used but is obsolete, as this substance 
is a purely “ laboratory” product which does not 
occur in nature.
Porphyriauria.—This term designates an in­
crease in the amount of urinary porphyrins 
without regard to the type of porphyrins present. 
The definition as such permits porphyria to be 
called a porphyrinuria, but in common and 
accepted usage the term porphyria is applied 
only to those individuals excreting excessive 
amounts of uroporphyrins .and/or porphobi­
linogen. In a large number of conditions there 
is an increased urinary coproporphyrin excre­
tion, and it is these which are commonly termed
CHLOROPHYLL
FIGURE 1
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porphyrinurias or, more correctly, secondary 
coproporphyrinurias (Table I).
Table I
P orphyrinurias 
(Secondary Coproporphyrinuria) 
COPROPORPHYRIN I COPROPORPHYRIN III
A c u t e  febrile states 
(pneumonia, lung 
abscess).
Infective hepatitis, Non­
alcoholic cirrhosis.
Rheumatic fever, polio­
myelitis.
Alcoholic cirrhosis, acute 
alcoholism.
Obstructive jaundice. Hodgkin’s disease.
Pernicious and haemo- Iron-deficiency anaemia,
lytic anaemias, leukaemia. aplastic anaemia.
Lead poisoning.
Mention is only made of these conditions in 
order to show what is not porphyria and to 
discourage the inexact use of the term por­
phyrinuria.
Idiopathic Coproporphyrinuria.—Occasional
individuals exhibit a physiological copropor­
phyrinuria III. This is an asymptomatic con­
dition with no history or signs of exposure to 
infections, chemical poisons or other agents 
likely to lead to coproporphyrinuria. Adults are 
mainly affected and it is usually not familial, 
although cases of hereditary coproporphyrinuria 
have been recently described.
The definitive diagnosis of porphyria is 
established by the demonstration by qualitative 
means of uroporphyrin or of the colourless 
chromogen porphobilinogen in the urine.
It should be remembered that patients with 
porphyria may at times excrete no porphyrins 
in their urine and that the quantity excreted 
at different times varies very greatly. Negative 
tests in a clinically suspect case do not exclude 
the diagnosis, and repeated examinations should 
be made.
T h e  Human P orphyrias 
These are inborn errors of metabolism, charac­
terised by the excretion of large amounts of 
uroporphyrin and/or porphobilinogen. In re­
cent years the understanding of the porphyrias
INTERMEDIATE 
MULTIPLE PYROLLES— •
A
•UROPORPHYRIN III COPROPORPHYRIN I I I
PORPHOBILINOGEN
A
DELTA-AMINOLEVULINIC
ACID
A
SUCCINATE +  GLYCINE
\
\
M
UROPORPHYRIN I
V
COPROPORPHYRIN I
Y
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V
PROTOPORPHYRIN I I I
+(Fe)I
HAEM
+  PROTEINS
Y
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\
FIGURE 2 . SYNTHESIS OF PORPHYRINS AND HAEM COMPOUNDS
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has undergone significant changes, and while 
controversy still exists regarding classification, 
it is now widely accepted that the disease can 
be divided into two principal categories based 
on the site of origin of the abnormal porphyrins 
(Watson et al., 1951).
1. Erythropoietic Porphyria—
(Congenital; photosensitive.)
2. Hepatic Porphyria—
(a) Acute intermittent.
(b) Chronic cutaneous (Cutanea tarda).
(c) “Mixed.”
(d) Latent.
Erythropoietic Porphyria.
The disorder is essentially one concerning the 
synthesis of haemoglobin from porphyrins, and 
the metabolic defect is located in the developing 
normoblasts of the bone marrow where excessive 
amounts of uroporphyrin I and coproporphyrin 
I are formed and liberated. These porphyrins 
permeate the tissues and appear in high con­
centrations in the excreta. The high concen­
tration of porphyrin in the normoblastic nuclei 
can be well shown by fluorescence microscopy.
Hepatic Porphyria.
In striking contrast to the erythropoietic type, 
the bone marrow and its porphyrin content are 
normal. The abnormality apparently resides in 
the liver where the enzyme catalase has been 
implicated, and liver disease or hepatic func­
tional impairment can be demonstrated in a 
high proportion of cases. Fluorescence micro­
scopy of the liver in the cutanea tarda type 
reveals large amounts of preformed uropor­
phyrins which fluoresce, while in the acute 
intermittent type there is relatively little fluo­
rescence, but non-fluorescing porphobilinogen is 
readily demonstrated in considerable quantities 
in the liver. In the “mixed” types, varying 
transitions are noted and the ratio of fluorescing 
porphyrin to non-fluorescing precursor varies 
from time to time. In the hepatic porphyrias 
both urine and faeces contain excessive amounts 
of coproporphyrin, uroporphyrin and porpho­
bilinogen. The uroporphyrin is present mainly 
as a zinc complex, whereas in the erythropoietic 
form it is mainly in the free state.
Inheritance in Porphyria.
The erythropoietic form of porphyria has 
been shown to be familial in exceptional cases 
only. It is probably inherited as a Mendelian
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recessive character, and despite attempts to prove 
that males are more frequently affected than 
females, there seems to be no fundamental sex 
difference in the incidence.
On the other hand, the hepatic forms are 
commonly familial, and if a careful search is 
made for latent or mild cases in the families of 
the patient the existence of the genetic trait is 
more often than not apparent. Dean and 
Barnes (1955) have demonstrated in a most 
fascinating study that in South Africans of 
European stock porphyria is inherited as a 
Mendelian dominant characteristic and is not 
sex-linked. Acute intermittent, cutanea tarda 
and latent forms may all occur in the one 
family, and in many cases one clinical type may 
turn into another. In Africans the familial 
incidence has been demonstrated in a few cases 
in South Africa, hut the problem of tracing 
families is a more difficult task with a migrant 
labour force and it is likely that amongst the 
more urbanised African population familial ten­
dencies will be more readily traced.
Since the early days of interest in this con­
dition the term “ toxic” has been used to imply 
that some cases were of an acquired nature due 
to the exhibition of toxic chemicals. While it 
cannot be questioned that hepatic porphyria is 
frequently precipitated by barbiturates, alcohol 
and other factors, it may well be that this has 
occurred in individuals with latent porphyria 
previously free of symptoms. Indeed, it has 
been frequently demonstrated that these drugs 
may precipitate clinical attacks in persons with 
known latent porphyria identified because their 
relatives had manifest clinical signs of the 
disease. It seems “not proven” that any of 
these drugs or procedures are capable of pro­
ducing porphyria de novo, and the existence of 
acquired or “ toxic” porphyria is questionable.
Clin ical  F eatures of t h e  P orphyrias 
as S een  in E uropeans
A. Erythropoietic.
This is a very rare condition, comprising 
about 2 per cent, of all the porphyrias. The 
term congenital is unsatisfactory, for although 
the trait is certainly present at birth, in a num­
ber of cases the symptoms fail to appear until 
several years after birth. There is usually, 
however, an early onset and red urine may be 
noticed on the nappies. In most cases the con­
dition is not apparent until the child becomes 
more exposed to sunlight. Uroporphyrin I has 
been shown to have marked photodynamic
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activity and is almost certainly responsible for 
the lesions in this type of porphyria.
Skin Lesions.—Exposure to sunlight is fol­
lowed by erythema and/or extensive bullous 
eruptions, which become pustular, leave shallow 
ulcers and heal slowly with, crusting, pigmenta­
tion and depigmentation and the development 
of shallow scars. This skin condition is known 
as hydroea aestivale and it can also occur in 
non-porphyric subjects. In porphyria, however, 
extensive mutilation can occur with loss of 
fingers, portions of the nose and ears, scarring 
and loss of elasticity about the cheeks and 
mouth, and scarring of the conjunctiva and 
cornea with resultant blindness. These effects 
are not seen in non-porphyric hydroea aestivale. 
The end-results must be distinguished from 
advanced xeroderma pigmentosa, scleroderma 
and leprosy, it being of interest to note that 
the first African case of congenital porphyria 
was referred from a leprosy institution. Hirsut­
ism is common, and while not usually extensive, 
a “bearded lady” with congenital porphyria has 
been described. The deciduous teeth are usually 
stained a reddish-brown or lavender colour by 
deposits of porphyrin in the tooth substance; 
even when the teeth are not obviously 
discoloured, they will fluoresce a bright red 
under ultra-violet light. The spleen is usually 
moderately enlarged and a haemolytic process 
is nearly always present, associated with a 
reticulocytosis and a normoblastic hyperplasia 
of the bone-marrow. Studies suggest that the 
abnormality responsible for the haemolytic pro­
cess is an intracorpuscular one. In some cases 
splenectomy has been followed by an improve­
ment in the haemolytic process and also in the 
photosensitivity. It seems that splenectomy by 
eliminating the increased haemolytic activity 
has produced a reduced erythropoiesis and hence 
a reduction in porphyrin formation, which in 
turn accounts for the reduced photosensitivity. 
The urine varies from pink to port wine to 
black, depending on the concentration of the 
porphyrins and the state of oxidation, and both 
urine and stools contain large amounts of uro- 
and coproporphyrin I, but no porphobilinogen. 
Bone-marrow porphyrin levels are greatly ele­
vated, while the liver contains normal or very 
slightly raised concentrations.
The prognosis in these cases is not altogether 
gloomy, and although scarring and deformiLy 
are the most spectacular aspects, it is anaemia 
and intercurrent infections which cause death. 
Treatment is usually directed to the prevention 
of the effects of photosensitivity and control of 
the haemolysis. Para-amino benzoic acid cream
has been used to protect the skin, and in some 
cases splenectomy has been successful in treat­
ing both the anaemia and the photosensitive 
lesions.
B. Hepatic.
This is the largest and most important group, 
comprising about 98 per cent, of ail cases of 
porphyria. The relative incidence of the vari­
ous sub-groups may differ according to the 
geography and race, e.g., in U.S.A, there are 
about three acute cases for every delayed 
cutaneous or mixed case, while among Africans 
in South Africa acute cases are extremely rare, 
the cutanea tarda type being seen almost ex­
clusively. Functional impairment of the liver 
or established liver disease is often observed 
in this group, especially in the cutanea tarda 
and mixed types; it is not a particular feature 
of the acute intermittent variety. One cannot 
yet draw any conclusion about the relationship 
of the hepatic disturbance to the porphyria; in 
Europeans the strong familial incidence suggests 
that liver affection is secondary to the porphyria, 
while in Africans it remains a possibility that 
it may be an acquired condition secondary to 
liver disorder.
One feature common to all the types of hepatic 
porphyria is the intermittency, and mild attacks 
of the various manifestations are more common 
than the severe ones. The diagnosis must be 
considered in any unexplained abdominal pain, 
particularly if recurrent, and in obscure mental 
disturbances and neurological disorders, includ­
ing coma, convulsions and peripheral neuro­
pathy. Recurrent skin lesions or jaundice may 
uncommonly be the presenting features, and 
even in acute malignant hypertension the possi­
bility of hepatic porphyria must be kept in mind 
(Case 1).
(1) Acute Intermittent Porphyria.
Females are affected twice as frequently as 
males and the condition is not usually manifest 
until the age of 20 or so. Most acute attacks 
are ushered in by abdominal pain (70 per 
cent.), mental (15 per cent.) or nervous (10 
per cent.) manifestations. Acute attacks are 
often precipitated by drugs or surgical pro­
cedures ; the exact mechanism by which this 
happens is not established. Although barbitur­
ates are the best known, alcohol is a much 
more commonly incriminated agent, and rarely 
sulphonamides and other drugs are responsible,
(a) Gastro-Intestinal Symptoms.—Paroxysms
of generalised abdominal colic are the most
common manifestation. The pain can be ex-
0
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cruciating, but little or no abdominal tenderness 
or rigidity occurs and it may radiate into the 
flanks or downwards into the groins. Frequently 
it is associated with severe constipation, com­
monly with nausea, vomiting and abdominal 
distension. The colic is certainly due to the 
painful spasm and dilatation of the bowel. 
Nearly all females with this condition bear the 
scars of frequent surgery and many of them 
have had their gall-bladders, ovaries or appen­
dices removed in their search for relief from 
pain. A leucocytosis occurs in less than 10 per 
cent, of cases, but when present it can make 
diagnosis even more difficult than usual.
(b) Central Nervous System. — Typically, 
pains occur in the lower limbs and arms, fol­
lowed by paraesthesiae, weakness and loss of 
deep reflexes and sensation. The findings are 
either those of a diffuse polyneuritis or a slowly 
ascending polyneuritis which may involve 
medullary centres causing bulbar paralysis. 
The resemblance to Guillan-Barre syndrome and 
to poliomyelitis can be marked and an abnormal 
cerebrospinal fluid is a not infrequent finding 
(30 per cent.). Sensory changes are generally 
mild. Cranial nerve involvement is usually 
evidenced by paresis of the vocal cords with 
hoarseness and occasionally by weakness of the 
ocular muscles. Episodic stupor and coma can 
occur, and epileptic attacks or atypical con­
vulsions are very common, usually occurring in 
those who have already shown other manifesta­
tions of porphyria.
(c) Hypertension is common in acute attacks, 
sometimes preceding attacks of abdominal pain 
by several days and occasionally being pro­
minent when paralysis is most marked. The 
hypertension is considered by some to be similar 
to that seen in bulbar poliomyelitis, as patho­
logical changes have been noted in the reticular 
formation, E.C.G. changes have been noticed 
in association with the hypertension and are 
believed to be due to coronary artery spasm. 
Of these hypertensive patients, 27 per cent, have 
elevated blood urea levels irrespective of the 
height of the blood pressure.
(d) Although mental and emotional disturb­
ances are considered to be of grave prognosis 
and to precede coma and death, this is certainly 
riot invariable. Hallucinations are frequent 
when the C.N.S. involvement is severe and 
schizophrenic states are not uncommon, but 
complete and rapid recovery can occur from an 
apparently deep psychotic state. It is of interest 
to recall that Waldenstrom found most of his 
cases of porphyria by a routine survey of the
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urine from patients in a Swedish mental 
hospital.
(e) Spasm of the retinal vessels may be seen, 
particularly during periods of hypertension, and 
temporary loss of vision has been reported.
(f) Tachycardia is very frequent during acute 
episodes, especially in the abdominal crises. 
However, bradycardia is not rare and has been 
a marked feature of one case which I have seen. 
This patient evidenced pulse rates of 40-60/ 
minute during severe attacks of acute abdominal 
pain, the pulse rate returning to normal as the 
pain subsided.
(g) Hirsutism may be marked on exposed 
areas, usually in females, and diffuse pigmen­
tation of the exposed parts is common.
(h) Electro-encephalograms: From a study of 
the tracings in four patients with acute porphyria 
over several years, we have shown (Shaper and 
Hughes, 1958) that during acute exacerbations 
there is a generalised theta and delta activity 
in proportion to the severity of the clinical mani­
festations of the cerebral damage. After fre­
quent attacks permanent damage may result, 
leading to permanent changes in the E.E.G, and 
to histologically demonstrable changes in the 
central nervous system.
The Prognosis.—Acute attacks may prove 
fatal, ascending paralysis with respiratory 
failure being a not uncommon form of death. 
Mortality is high in. those with nervous system 
manifestations,, and probably 50 per cent, of 
these do not recover.
The Urine in Acute Intermittent Porphyria.— 
The urine may be normal in colour when 
passed, even during acute episodes, or it may 
merely look concentrated. If left in daylight 
for a few hours it becomes amber, particularly 
near the surface. Most cases, however, will 
have noticed a darkening of the colour at the 
outset of their disorder. The urine usually 
contains porphobilinogen, zinc complexes of 
uroporphyrin and coproporphyrin. Porphobi­
linogen is very rarely found, apart from por­
phyria, although Watson has described several 
such cases with liver disease (4), malignant 
disease (4), and bulbar polio, Guillain-Barre 
syndrome and bacterial endocarditis. These 11 
cases have unfortunately led to the widespread 
belief that porphobilinogenuria is common in 
hepatic disease, malignant disease and any
C.N.S. infection. It may well be that these 
cases all had latent porphyria. To complicate 
matters, in a recent survey of 80 cases seen at
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the Mayo Clinic it was noted that no porpho­
bilinogen was found in nine cases with severe 
C.N.S. involvement and in six cases with abdo­
minal crises. In a further six cases no uro­
porphyrin was detected despite the presence of 
porphobilinogen and coproporphyrin. It should 
be emphasised that porphyrin excretions may 
be intermittent.
Case 1. Acute Intermittent Porphyria. Fe­
male aged 23 years.
In June, 1954, this patient noticed her urine was 
red in colour, and two months later she developed 
fever, constipation and lower abdominal pain, again 
associated with red urine. Within a few days she 
became confused and disorientated, complained of 
severe headache and blurred vision and then experienced 
two major epileptic attacks. On admission to hospital 
(August) she was febrile and wasted, B.P. 150/110. 
Blood urea was 110 mg. per 100 ml. Optic fundi
normal and the brownish-red urine contained no pro­
tein or deposit. A few, days later she collapsed in 
the ward and was found to be acutely hallucinated. 
Diagnosed as a “ depressive state with schizophrenic 
symptoms,” she was transferred to a mental hospital 
(September, 1954). Here she was found to be drowsy 
and restless, her speech was slurred and she com­
plained bitterly of pains and paraesthesiae all over 
the body. Bilateral papilloedema was noted, B.P. 
170/120 and the blood urea rose to 138 mg. per 100 ml. 
Although exudates developed, the papilloedema sub­
sided and over the next month she improved rapidly; 
blood urea returned to normal, although the hyper­
tension persisted. During this period she unfortunately 
received 12 grains of barbiturate drugs, and by 5th 
October, although mentally clear, she had developed 
a complete flaccid paralysis with slight ptosis and 
dysphonia. Lumbar puncture on the tenth day of 
paralysis showed a normal cerebrospinal fluid, but was 
followed by five severe epileptiform convulsions in one 
hour.
Transferred to a general hospital (14th October)', she 
was emaciated, with complete flaccid paralysis and limb 
contractures, B.P. 120/65 and normal fundi (Fig. 3). The 
urine contained uroporphyrin, porphobilinogen and 
urobilinogen and the blood urea was 66 mg. per 100 ml. 
Treatment with prostigmine for one week was without 
effect. On 30th November, following limb pains and 
headaches for two days, she suddenly complained of
blindness and acute abdominal pain and became con­
fused and restless. B.P. rose to 160/130, the fundi 
were pale, with the arterioles in spasm, and neck 
rigidity was marked. Vision returned rapidly to normal, 
the abdominal pain subsided, but hypertension per­
sisted and the retinal vessels remained in spasm. In 
December, 1954, there was a further period of confu­
sion, shouting and singing, followed by two days of 
smiling cheerfulness; then followed a vivid hallucina­
tion and a severe epileptiform convulsion. Further 
episodes of confusion and hallucinations occurred, and 
in January, 1956, papilloedema was again noted to be 
present. Scattered retinal exudates and haemorrhages 
developed and a perimacular “star” was noted in the 
right lundus. By March, 1956, she could write, feed 
herself and walk a few steps with assistance, and as 
hypertension had now been present for four months 
Serpasil was given, the B.P. falling to normal levels 
within two weeks. Papilloedema subsided, the exudates 
appeared to be absorbing, and when discharged in ' 
June she weighed 80 lbs., had bilateral footdrop and 
weakness of the hands. Her urine still contained 
porphyrins. She is at present well (1957) and able to 
care for her home and her family without assistance.
(2) Chronic Cutaneous Porphyria (Cutanea 
tarda).
This is also familial, runs a mild course and 
has a fairly good prognosis, which usually de­
pends on the course of any associated liver 
disease. It seems to occur particularly in adults 
in the 40’s and 50’s, more commonly in males 
and is characterised clinically by the occurrence 
of skin photosensitivity and pigmentation, and 
evidence of liver disease is frequently encoun­
tered; histologically there may be cell injury, 
fatty liver or frank cirrhosis. Kark (1955) 
considers that all this group have had hepatic 
disease before they developed porphyria and 
skin manifestations, but his is not a generally 
accepted view.. The skin lesions closely resemble 
those of erythropoietic porphyria in their photo­
sensitivity, but are milder and do not lead to 
mutilation. Occasionally lesions may be urti­
carial or eczemoid in appearance. Discrete 
pigmented macules may occur and hypertrichosis
Figure 3.—Case 1 (acute intermittent porphyria). Condition on admission, October, 1954.
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may be marked, especially in women. Not 
uncommonly, diabetes mellitus is an associated 
finding. Jaundice may be severe and mild
abdominal pain may accompany the recurrent 
crops of skin blisters. They usually pass a 
reddish urine which contains the same porphy­
rins excreted in the acute intermittent type, 
except that porphobilinogen is not present in 
these cases.
Case 2. Chronic Cutaneous Porphyria. Male 
aged 42.
In 1942 (aet. 30), after 15 months in Burma, this 
patient developed a bullous eruption on face and 
hands. Crops of vesicles, occasionally confluent, ap­
peared, especially on bruised or injured areas where 
the vesicle might be haemorrhagic. If infected, the 
vesicles would become scarred and pigmented. This 
condition recurred daily for three months. In 1951 
he experienced a similar episode in Persia, mainly 
involving the backs of the hands; in 1953 during the 
summer in England he had a more severe eruption, 
with desquamation of the backs of the hands. Apart 
from the skin lesions, there has been no constitutional 
disturbance. A heavy beer-drinker at week-ends; no 
family history of similar disorders.
On examination, he was a dark-skinned man with 
pitted scars about 1 cm. in diameter on forehead and 
upper face and a few fresh broken bullae on the ears 
and forehead. The hands showed scattered lesions 
from scars to fresh bullae, with milia in some of the 
fresh scars. The skin was slightly thickened.
The urine contained slightly increased urobilinogen, 
no porphobilinogen, increased coproporphyrin and uro­
porphyrin I and a small amount of uroporphyrin III. 
All liver function tests and other investigations were 
normal. Bone-marrow showed no fluorescence, and on 
liver biopsy the cells appeared normal, but showed a 
diffuse red fluorescence under ultraviolet light.
The patient was treated with vitamin B12, 100 micro­
grams daily for 10 days, and PABA cream, and he 
appeared to show some improvement.
(3) “Mixed”  or Combined Porphyria.
This is a term used for those patients present­
ing with abdominal pain or nervous symptoms, 
or both, in association with porphobilinogen in 
the urine, either during the course of chronic 
cutaneous porphyria or when photosensitivity is 
in remission. In other cases acute symptoms 
may have been manifest well before any 
cutaneous lesions occur. This group emphasises 
the close relationship between the various sub- 
types of hepatic porphyria.
Case 3. “Mixed” Porphyria.
March, 1948. One week after Pentothal had been 
given for a gynaecological operation, Mrs.-M. J., aged 
48 years, developed abdominal pain, nausea and vomit­
ing, behaved in a rather hysterical manner and was 
rapidly discharged from hospital. At home, progressive 
weakness followed, and five weeks after her operation 
she was readmitted with a complete flaccid paralysis. 
She then received 35 gr. barbiturate over six weeks, 
discontinued only when jaundice developed in the
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seventh week. Liver and spleen were enlarged and 
tender, the urine contained bilirubin and the serum 
bilirubin rose to 40 mg. per cent. Jaundice persisted 
at this level with dark urine and pale stools for six 
weeks, then slowly subsided over a further four weeks. 
She then received 15 gr. barbiturate over a further 
week, and soon after the initial dose manifested a 
bullous skin eruption. Crops of these bullae appeared 
daily for three months and then disappeared.
September, 1955: Two months’ intermittent epigastric 
pain and loss of weight, then for one week acute 
abdominal pain, constipation, vomiting and passage of 
dark urine. B.P. 150/90 on admission, but this soon 
rose to 185/120 mm. Hg. and the retinal arterioles 
were seen to be in -marked intermittent spasm. Urine 
contained uroporphyrin and porphobilinogen; serum 
bilirubin 1.8 mg. per 100 ml.
Treatment with small doses of Serpasil and Ansoly- 
sen orally produced a -precipitous fall in B.P. which 
necessitated the use of a noradrenaline infusion, and 
on a later occasion Largactil had a similar disastrous 
effect, also requiring noradrenaline. Following -these 
incidents she had no return of abdominal pain or 
hypertension and slowly returned to normal. Since 
then she has had occasional abdominal pain, a mild 
hypertension and persistent porphyrins in the urine.
Treatment of Hepatic Porphyria.
There is no treatment which will rid the 
patient with porphyria of his disease. Needless 
to say, barbiturates and alcohol are contra­
indicated. Both ganglion-blocking agents and 
chlorpromazine have been used with success in 
cases with abdominal pain, but Case 3 illustrates 
that these drugs should be used with caution, 
as individual patients may exhibit undue sensi­
tivity. The value of corticotrophin and corti­
sone is not established, although in most series 
of cases so treated one or more have shown a 
dramatic response. Pethidine, methadone and 
paraldehyde do not precipitate attacks or aggra­
vate the established episode and may be freely 
used.
The Fundi in Porphyria.
In reported cases of porphyria, blurred discs 
have occasionally been noted, while the spasm 
occurring in the retinal vessels is frequently 
commented upon. This spasm may be severe 
and present for many weeks (Case 1) or may 
merely present as intermittent spasm (Case 3). 
Papilloedema (Case 1) has not previously been 
described in this condition. Barnes and Boshoff 
(1952) have reviewed the ocular lesions in 84 
cases, including 46 not of European descent.
In the acute phase of hepatic porphyria, round 
cotton wool patches were seen which may leave 
a diffuse granulating or, if they persist longer 
than three weeks, rounded peripheral blobs of 
brownish or black pigment. Thin flat striate 
patches are also seen which leave pale scars 
with pigment striations.
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In the chronic forms of porphyria discrete 
annular lesions of the choroid are seen, as well 
as denser clover-leaf lesions spreading out from 
the disc. While not diagnostic of porphyria, 
the retinal findings they describe warrant an 
extensive search for porphyria, especially if they 
occur in association with suggestive clinical 
features.
P orphyria  in A fricans
There is no basic difference in the clinical 
patterns from those seen in Europeans, and all 
that has been said previously applies to cases 
in Africans, but acute intermittent cases are 
very rare, the vast majority being benign and 
showing the characteristic skin lesions of chronic 
cutaneous porphyria.
Two cases of erythropoietic porphyria have 
been described in South Africa, the first in a 
13-year-old African girl referred from a leper 
institute. She was a typical case with uropor­
phyrin and coproporphyrin I in the urine, no 
porphobilinogen and a normal liver histologically 
and under ultra-violet microscopy.
A recent report from the Northern Sudan 
describes two cases of erythropoietic porphyria 
in a brother and sister, the bone-marrow of both 
showing abundant fluorescing normoblasts under 
ultra-violet light.
Contrary to usual reports of cutaneous por­
phyria, there is a predominance of females, 
although in South Africans of European stock 
males more frequently show pronounced skin 
lesions and the females more frequently present 
with acute attacks. The age incidence shows 
few cases below 20 years, the majority occurring 
between 30 and 50 years of age. The condition 
is only occasionally found to be familial, but 
as the lesions are mild and few of the reported 
cases actually presented themselves on account 
of their porphyria, it seems most unlikely that 
they would have recognised a similar condition 
in their relatives.
Presenting Features.—About one-third present 
with the characteristic “blistering” skin lesions, 
the remainder attending for reasons bearing no 
relation to porphyria whatsoever. In over 20 
per cent, of cases seen on the Witwatersrand a 
diagnosis of pellagra had been made, and it 
should be pointed out- that contrary to earlier 
reports and contrary to what may still be seen 
in several textbooks, pellagra is not associated 
with an increase in porphyrin excretions. There 
were also a fair number of cases diagnosed as 
pemphigus, dermatitis herpetiformis, hydroea 
aestivale and Steven-Johnson syndrome.
Skin Lesions.—Some have recurrent attacks; 
others are continuously affected. The bullae 
usually occur on the exposed parts, sometimes 
following slight trauma; they may occur on 
fingers and hands, and have been occasionally 
seen on buccal mucosa, tongue, oral pharynx 
and the mucocutaneous junctions of the lower 
lip. They vary from a few mm. to several cm. 
in diameter and contain a clear fluid; occa­
sionally this fluid is reddish or brown. The 
blisters break to leave a clean raw erosion which 
takes one to two weeks to heal. The scar 
resulting from these lesions can be seen for a 
long time as a hyper- or hypo-pigmented patch. 
Small milia (epidermal cysts) may be found 
in the scars, and the new skin may show “ tissue- 
paper” atrophy. If secondary infection has 
taken place, extensive fibrous scarring may be 
seen, but one does not see the mutilation which 
is seen in congenital porphyria. In some cases 
a velvety warty hyperkeratosis is found over the 
dorsal surfaces of the two terminal finger-joints 
which Marshall considers significant of porphyria 
if it occurs in association with bullous lesions.
Nail Lesions.—Subungual blisters lead to 
softening, loosening, splitting and deformity of 
the nails. Cracking and peeling occur with 
atrophy or loss of part of the nail, usually the 
distal portion.
Hyperpigmentation.—Generalised darkening
of the skin over the face and hands is common 
and may be very marked in some cases. In 
some of these cases the diagnosis of pellagra may 
be made. Gelfand (1955) examined the urines 
of 15 subjects with very dark facial pigmentation 
and found no porphyrins present.
Hypertrichosis over the temporal and pre- 
auricular regions is not uncommon, but as soft 
facial hair is common in Africans this may not 
be a particularly important feature in diagnosis, 
the more so as it is never seen without co-existing 
skin lesions or hyperpigmentation.
Serology.—Of the Johannesburg cases, 50 per 
cent, showed a positive Kahn reaction, and one 
presumes this is merely a reflection of the high 
incidence of venereal disease on the Rand.
Liver Disease.—Over half the cases seen in 
South and Central Africa have hepatic enlarge­
ment and excess urobilinogen in the urine, and 
on the basis of these features, and on abnormal 
“liver function” tests, it has been supposed that 
most African cases show some signs of liver 
involvement. The Africans in Rhodesia regard 
the condition as being due to “ skokiaan” and 
Gelfand (1955) found that most of his cases 
drank it regularly.
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If it is an acquired condition, almost certainly 
alcohol, malnutrition and liver disease are the 
factors most probably to be incriminated in 
porphyria in Africans. The study of this con­
dition requires full hepatic function investiga­
tion of all these cases, particularly the latent 
cases of porphyria who have as yet manifested 
no clinical symptoms of their condition.
S creening Tests for the Porphyrias
Spectroscopy.—The instrument recommended 
by Barnes is the Beck spectroscope. On spectro­
scopy the bands of porphyrin and oxyhaemo- 
glohin are essentially similar, two absorption 
hands in the green, and cannot be differentiated 
with the ordinary spectroscope.
If the urine is made strongly acid by adding 25 per 
cent, v/v of concentrated HC1, a porphyrin-hydro­
chloride spectrum may be seen, with a strong absorp­
tion band at 553 mu and a relatively weak band at 
597 mu. Oxyhaemoglobin treated in this way yields 
acid haematin with a broad diffuse band in the red 
(630-640 mu). Barnes recommends examination of a 
5-inch column of filtered urine downward along the 
axis of the test tube, using untreated urine and after 
making acid to Congo Red with concentrated HC1 
acid. He considers this method to be superior to 
examination under ultra-violet light.
Porphobilinogen . (intermittent porphyria; mixed 
porphyria).
(1) To 1 ml. fresh urine add 1 ml. of Erlich’s re­
agent and mix.
(2) Add 4 ml. supersaturated aqueous solution of 
sodium acetate and mix.
(3) Test with Congo Red paper, which should give 
a red reaction.
(4) Add approximately 3 ml chloroform and mix 
vigorously.
(5) Allow to separate into water and chloroform 
layers.
Porphobilinogen, if present, will form a 
brown-red aldehyde on adding Erlich’s reagent. 
This colour will stay in the aqueous layer after 
mixing with chloroform. Urobilinogen will 
form a purple-red aldehyde which will migrate 
into the chloroform layer after mixing. Faint 
orange or pink reactions should be disregarded 
or the urine submitted to spectroscopy.
If the urine is rich in urobilinogen one can 
either transfer the aqueous layer to another tube 
and shake with more chloroform on several 
occasions, or the urine can be diluted 1 in 5, 
acidified with acetic acid and extracted three 
times with ethyl acetate. Any positive reaction 
after these procedures is due to porphobilinogen.
Uroporphyrin (intermittent, mixed, delayed 
cutaneous, congenital).
(1) In the dark, irradiate 10 ml. urine with ultra­
violet light. If uroporphyrin is present the 
urine will fluoresce red or orange-red.
(2) If this is negative, acidify the urine to about 
pH 4 with acetic acid (approx. 2 ml.), heat 
for 15 minutes in a water-bath and expose in-
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the dark to ultra-violet light. (Heat at pH 4 
converts non-fluorescing porphobilinogen to 
fluorescing uroporphyrin.)
Coproporphyrin (lead poisoning, secondary 
porphyrinurias).
(1) Add 2 ml. glacial acetic acid to 10 ml. fresh 
urine.
(2) Add 30 ml. ether and shake vigorously; allow 
to separate into two layers.
(3) Examine in the dark under ultra-violet light. 
A bright red fluorescence in the ether layer 
indicates the presence of massive porphyrinuria 
due to ether-soluble porphyrin.
Stools.
(1) (Saunders.) A knife edge of wet stool is dis­
solved in 3 ml, of a solution of equal parts amyl 
alcohol, ether and glacial acetic acid. This is 
placed under ultra-violet light, and if brilliant 
red fluorescence is obtained it is probably diag­
nostic of porphyria.
(2) (Barnes.) Loopful of faeces mixed in l  ml. 
of glacial acetic acid with a glass rod and then 
mixed with 2.5 ml. Other. The solids settle 
rapidly and the supernatant can be examined in 
ultra-violet light. Normal stool extracts show 
a greenish fluorescence. Bright pink or red 
fluorescence indicates porphyrin. The porphyrins 
from chlorophyll in food can be distinguished 
by pouring the extract into a clean tube and 
shaking with 0.5 ml. 1.5 N HC1 (15 ml. con­
centrated H Cl dilute to 100 ml. with water). 
Re-examine in ultra-violet light. Haem por­
phyrins pass into the acid layer and chlorophyll 
porphyrins remain in the ether.
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